Show simple item record

dc.contributor.authorDi Benedetto, Anna
dc.contributor.authorMottolese, Marcella
dc.contributor.authorSperati, Francesca
dc.contributor.authorErcolani, Cristiana
dc.contributor.authorDi Lauro, Luigi
dc.contributor.authorPizzuti, Laura
dc.contributor.authorVici, Patrizia
dc.contributor.authorTerrenato, Irene
dc.contributor.authorSperduti, Isabella
dc.contributor.authorShaaban, Abeer M
dc.contributor.authorSundara-Rajan, Sreekumar
dc.contributor.authorBarba, Maddalena
dc.contributor.authorSpeirs, Valerie
dc.contributor.authorDe Maria, Ruggero
dc.contributor.authorMaugeri-Saccà, Marcello
dc.date.accessioned2018-07-20T15:48:06Z
dc.date.available2018-07-20T15:48:06Z
dc.date.issued2016-07-12
dc.identifier.citationDi Benedetto , A , Mottolese , M , Sperati , F , Ercolani , C , Di Lauro , L , Pizzuti , L , Vici , P , Terrenato , I , Sperduti , I , Shaaban , A M , Sundara-Rajan , S , Barba , M , Speirs , V , De Maria , R & Maugeri-Saccà , M 2016 , ' The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer ' , Oncotarget , vol. 7 , no. 28 , pp. 43188-43198 . https://doi.org/10.18632/oncotarget.9668en
dc.identifier.otherPURE: 129546843
dc.identifier.otherPURE UUID: 1cf32514-0f8d-4431-aff5-1a9dc14f3b3d
dc.identifier.otherPubMed: 27248471
dc.identifier.otherPubMedCentral: PMC5190017
dc.identifier.otherScopus: 84978633507
dc.identifier.otherORCID: /0000-0002-0602-4666/work/72631250
dc.identifier.urihttp://hdl.handle.net/2164/10775
dc.descriptionThis study was supported by the “Associazione Italiana per la Ricerca sul Cancro” (AIRC IG Grant N:13431 to RDM), and by Breast Cancer Now (formerly Breast Cancer Campaign; grant 2007MayPR02 to VS and AMS), which provided funding for the accrual and construction of the MBC TMAs described.en
dc.format.extent11
dc.language.isoeng
dc.relation.ispartofOncotargeten
dc.rightslicensed under a Creative Commons Attribution 3.0 License https://creativecommons.org/licenses/by/3.0/en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectAdaptor Proteins, Signal Transducingen
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectBreast Neoplasms, Maleen
dc.subjectCarcinogenesisen
dc.subjectCarcinoma, Ductal, Breasten
dc.subjectConnective Tissue Growth Factoren
dc.subjectGene Expression Regulation, Neoplasticen
dc.subjectHumansen
dc.subjectImmunohistochemistryen
dc.subjectIntracellular Signaling Peptides and Proteinsen
dc.subjectKaplan-Meier Estimateen
dc.subjectKi-67 Antigenen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectNeoplasm Gradingen
dc.subjectPhenotypeen
dc.subjectPhosphoproteinsen
dc.subjectProportional Hazards Modelsen
dc.subjectProtein-Serine-Threonine Kinasesen
dc.subjectRare Diseasesen
dc.subjectReceptors, Steroiden
dc.subjectRetrospective Studiesen
dc.subjectSignal Transductionen
dc.subjectTissue Array Analysisen
dc.subjectJournal Articleen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleThe Hippo transducers TAZ/YAP and their target CTGF in male breast canceren
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.18632/oncotarget.9668
dc.identifier.vol7en
dc.identifier.iss28en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record